O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer
Identification of novel biomarkers is helpful for the diagnosis and treatment of cervical cancer. Mucin glycosylating enzyme GALNT2 modulates mucin O-glycosylation, and has been revealed as a regulator of tumorigenesis in various cancers. However, the expression pattern of GALNT2 in cervical cancer...
Gespeichert in:
Hauptverfasser: | Lixia Zhou (VerfasserIn), Huiqin Wu (VerfasserIn), Xingli Bai (VerfasserIn), Shuyun Min (VerfasserIn), Jiawen Zhang (VerfasserIn), Cunli Li (VerfasserIn) |
---|---|
Format: | Buch |
Veröffentlicht: |
Frontiers Media S.A.,
2022-08-01T00:00:00Z.
|
Schlagworte: | |
Online-Zugang: | Connect to this object online. |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Ähnliche Einträge
-
Increased Kremen2 predicts worse prognosis in colon cancer
von: Junxian Long, et al.
Veröffentlicht: (2023) -
High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer
von: Liwei Zhang, et al.
Veröffentlicht: (2022) -
A glycosylation-related gene signature predicts prognosis, immune microenvironment infiltration, and drug sensitivity in glioma
von: Yanbo Yang, et al.
Veröffentlicht: (2024) -
APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis
von: Xiying Cao, et al.
Veröffentlicht: (2023) -
Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis
von: Bing Lu, et al.
Veröffentlicht: (2024)